CalciMedica grants CBO 83,358 stock options
CalciMedica, Inc. reported that Chief Business Officer and 10% owner Eric W. Roberts received an option grant covering 83,358 shares of common stock.
Rhea-AI Filing Summary
CalciMedica, Inc. reported that Chief Business Officer and 10% owner Eric W. Roberts received an option grant covering 83,358 shares of common stock. The employee stock option has an exercise price of $0.585 per share and expires on April 4, 2036.
According to the vesting terms, beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over four years. No shares will vest until the company files a Form S-8 covering shares automatically added under its 2023 Equity Incentive Plan pursuant to an annual evergreen provision.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 83,358 shares
Grant/Award
1 txn
Insider
Roberts Eric W
Role
CHIEF BUSINESS OFFICER
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 83,358 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 83,358 contracts (Direct)
Footnotes (1)
- F1. Beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period, provided, however, that no shares shall vest until the filing of the Company's registration statement on Form S-8 covering the shares of Common Stock that were automatically added to the shares authorized for issuance under the Company's 2023 Equity Incentive Plan on January 1, 2026 pursuant to an annual "evergreen" provision.
Key Figures
Option grant size: 83,358 options
Exercise price: $0.585 per share
Expiration date: April 4, 2036
+2 more
5 metrics
Option grant size
83,358 options
Employee stock option covering common stock
Exercise price
$0.585 per share
Conversion or exercise price of employee stock option
Expiration date
April 4, 2036
Option term end date
Post-transaction derivative holdings
83,358 options
Total shares underlying options following transaction
Vesting commencement
April 1, 2026
1/48th of shares vest monthly from this date
Key Terms
Employee Stock Option, Form S-8, 2023 Equity Incentive Plan, evergreen provision
4 terms
Employee Stock Option financial
"security_title: "Employee Stock Option (Right to Buy)""
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
Form S-8 regulatory
"no shares shall vest until the filing of the Company's registration statement on Form S-8"
A Form S-8 is a U.S. Securities and Exchange Commission registration that lets a public company set aside shares for employee benefit plans and stock-based compensation. Think of it as opening a dedicated account that authorizes the company to issue or reserve stock for workers and directors; it matters to investors because it enables share dilution when those awards are granted or exercised and signals how management is compensated and incentivized.
2023 Equity Incentive Plan financial
"shares authorized for issuance under the Company's 2023 Equity Incentive Plan"
evergreen provision financial
"added to the shares authorized for issuance ... pursuant to an annual "evergreen" provision"
An evergreen provision is a clause in a financing or contract that automatically renews or replenishes the arrangement unless one party actively cancels it, like a subscription that keeps renewing each term. For investors it matters because it creates predictable, ongoing access to funding or ongoing contractual obligations — helping liquidity and planning — but can also hide long-term commitments or dilution risks if not reviewed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CalciMedica (CALC) report for Eric W. Roberts?
CalciMedica reported that Chief Business Officer Eric W. Roberts received an employee stock option covering 83,358 shares of common stock. The option was granted at an exercise price of $0.585 per share and is reported as a grant or award acquisition on the Form 4.
What are the key terms of Eric W. Roberts’ CalciMedica stock option grant?
The option covers 83,358 underlying common shares at an exercise price of $0.585 per share and expires April 4, 2036. It is characterized as an employee stock option (right to buy) and is held directly by Roberts following this reported transaction.
How and when do Eric W. Roberts’ CalciMedica options vest?
Beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over four years. However, no shares vest until CalciMedica files a Form S-8 covering shares automatically added under its 2023 Equity Incentive Plan’s evergreen provision.
Does the CalciMedica Form 4 show any stock sales by Eric W. Roberts?
The Form 4 shows no stock sales; it reports one derivative transaction classified as a grant or award acquisition. Roberts acquired 83,358 employee stock options, with total derivative holdings following the transaction shown as 83,358 options linked to common stock.
What is the expiration date of Eric W. Roberts’ CalciMedica stock options?
The employee stock option granted to Eric W. Roberts expires on April 4, 2036. After this date, any unexercised portion of the 83,358 underlying common shares can no longer be purchased at the stated $0.585 per share exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
